Hepcdac Daclatasvir Tablets
₹2,000.00 / Bottle
Specification
- form
- Tablet
- brand
- Cipla
- treatment
- Used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection
- shelf life
- 24 Months
- composition
- Daclatasvir
- dosage form
- Tablet
- indications
- Cure The Hepatitis C Virus
- availability
- In Stock
- packaging size
- 28 Tablet
- packaging type
- Box
- strength dosage
- 60 mg
Add Quantity
Bottle
Response within 4 hoursFree to enquire
Description
Hepcdac is used with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. These medications together reduce the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. On using this medication you may experience side effects such as nausea, headache, weakness, fatigue, breakdown of the red cell, diarrhoea, drowsiness, dizziness and skin rash. If your reactions persist or become worse over time seek the help of your health care provider right away. The dosage should be determined by the doctor based on your age, overall medical history and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally once daily for a period of 12 weeks. Product Description: Expiry – 1 Year to 2 Years Indication(s) – Hepatitic C Virus (HCV) Infection UPC / GTIN Barcode – No Prescription Required – Yes
Verify supplier credentials before transacting. Enquiries create leads for the supplier.